angiotensin ii, sar(1)-me-tyr(4)- has been researched along with arginine in 1 studies
Studies (angiotensin ii, sar(1)-me-tyr(4)-) | Trials (angiotensin ii, sar(1)-me-tyr(4)-) | Recent Studies (post-2010) (angiotensin ii, sar(1)-me-tyr(4)-) | Studies (arginine) | Trials (arginine) | Recent Studies (post-2010) (arginine) |
---|---|---|---|---|---|
25 | 0 | 0 | 46,388 | 1,688 | 11,176 |
Protein | Taxonomy | angiotensin ii, sar(1)-me-tyr(4)- (IC50) | arginine (IC50) |
---|---|---|---|
Cationic amino acid transporter 3 | Homo sapiens (human) | 283 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Belte, U; Cordopatis, P; Franklin, KJ; Ganter, RC; Goghari, MH; Matsoukas, J; Moore, GJ | 1 |
1 other study(ies) available for angiotensin ii, sar(1)-me-tyr(4)- and arginine
Article | Year |
---|---|
Importance of the N-terminal domain of the type II angiotensin antagonist sarmesin for receptor blockade.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arginine; Biological Assay; Chemical Phenomena; Chemistry; Female; Isoleucine; Methylation; Rats; Rats, Inbred Strains; Receptors, Angiotensin; Sarcosine; Structure-Activity Relationship; Uterus | 1988 |